Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Inhibitors of Lipolysis in the Treatment of Lipid a Glucose Metabolism in Obstructive Sleep Apnea Syndrome

NCT05245240 is registered in ClinicalTrials.gov with Faculty Hospital Kralovske Vinohrady as lead sponsor.

NCT NCT05245240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05245240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Inhibitors of Lipolysis in the Treatment of Lipid a Glucose Metabolism in Obstructive Sleep Apnea Syndrome
Lead sponsor
Faculty Hospital Kralovske Vinohrady
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2022
Completion date
December 31, 2024
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, obstructive sleep apnea